Rocío Pérez‐Iglesias

6.3k total citations
106 papers, 4.2k citations indexed

About

Rocío Pérez‐Iglesias is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rocío Pérez‐Iglesias has authored 106 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Psychiatry and Mental health, 31 papers in Cognitive Neuroscience and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rocío Pérez‐Iglesias's work include Schizophrenia research and treatment (75 papers), Functional Brain Connectivity Studies (27 papers) and Bipolar Disorder and Treatment (26 papers). Rocío Pérez‐Iglesias is often cited by papers focused on Schizophrenia research and treatment (75 papers), Functional Brain Connectivity Studies (27 papers) and Bipolar Disorder and Treatment (26 papers). Rocío Pérez‐Iglesias collaborates with scholars based in Spain, United Kingdom and United States. Rocío Pérez‐Iglesias's co-authors include Benedicto Crespo‐Facorro, José Luis Vázquez‐Barquero, José Manuel Rodríguez-Sánchez, Obdulia Martínez‐García, Ignácio F. Mata, César González‐Blanch, José María Pelayo‐Terán, Roberto Roiz‐Santiáñez, Diana Tordesillas‐Gutiérrez and Mario Álvarez‐Jiménez and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Rocío Pérez‐Iglesias

106 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rocío Pérez‐Iglesias Spain 40 2.9k 1.2k 730 553 537 106 4.2k
Renrong Wu China 33 1.5k 0.5× 1.3k 1.1× 715 1.0× 611 1.1× 441 0.8× 153 3.8k
Sameer Jauhar United Kingdom 27 1.8k 0.6× 673 0.6× 306 0.4× 318 0.6× 533 1.0× 103 3.4k
Emilio Fernández-Egea United Kingdom 33 1.5k 0.5× 723 0.6× 205 0.3× 506 0.9× 406 0.8× 131 3.1k
Eduard Parellada Spain 30 1.4k 0.5× 478 0.4× 240 0.3× 244 0.4× 322 0.6× 98 2.5k
Brian Sheitman United States 33 4.6k 1.6× 682 0.6× 163 0.2× 375 0.7× 1.7k 3.1× 87 6.0k
Keming Gao United States 39 2.3k 0.8× 930 0.8× 384 0.5× 627 1.1× 633 1.2× 138 4.8k
David Ames Australia 26 1.6k 0.5× 549 0.5× 330 0.5× 1.0k 1.9× 387 0.7× 99 3.4k
William H. Wilson United States 34 1.2k 0.4× 788 0.7× 354 0.5× 235 0.4× 621 1.2× 125 3.7k
Sanjiv Kumra United States 38 2.5k 0.9× 1.7k 1.5× 1.1k 1.6× 123 0.2× 811 1.5× 77 4.4k
Jean-Pierre Lindenmayer United States 29 2.9k 1.0× 533 0.5× 100 0.1× 342 0.6× 840 1.6× 43 4.0k

Countries citing papers authored by Rocío Pérez‐Iglesias

Since Specialization
Citations

This map shows the geographic impact of Rocío Pérez‐Iglesias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Pérez‐Iglesias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Pérez‐Iglesias more than expected).

Fields of papers citing papers by Rocío Pérez‐Iglesias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocío Pérez‐Iglesias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Pérez‐Iglesias. The network helps show where Rocío Pérez‐Iglesias may publish in the future.

Co-authorship network of co-authors of Rocío Pérez‐Iglesias

This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Pérez‐Iglesias. A scholar is included among the top collaborators of Rocío Pérez‐Iglesias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Pérez‐Iglesias. Rocío Pérez‐Iglesias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diago, Carlos Antonio Amado, Marcos Gómez‐Revuelta, María Juncal‐Ruíz, et al.. (2023). Individuals with psychosis present a reduced lung diffusion capacity and early spirometry alterations: Results from a cross-sectional study. Journal of Psychosomatic Research. 176. 111554–111554. 1 indexed citations
2.
Merritt, Kate, Rocío Pérez‐Iglesias, Kyra-Verena Sendt, et al.. (2019). Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate. Schizophrenia. 5(1). 12–12. 26 indexed citations
3.
Hickling, Lauren M., Rocío Pérez‐Iglesias, Ann McNeill, et al.. (2018). A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychological Medicine. 49(6). 1033–1040. 29 indexed citations
4.
Hickling, Lauren M., et al.. (2018). Non-adherence to antipsychotic medication in first-episode psychosis patients. Psychiatry Research. 264. 151–154. 22 indexed citations
5.
Hickling, Lauren M., Rocío Pérez‐Iglesias, Víctor Ortiz‐García de la Foz, et al.. (2017). Tobacco smoking and its association with cognition in first episode psychosis patients. Schizophrenia Research. 192. 269–273. 32 indexed citations
6.
Pérez‐Iglesias, Rocío, Obdulia Martínez‐García, Gema Pardo‐García, et al.. (2013). Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors. The International Journal of Neuropsychopharmacology. 17(1). 41–51. 91 indexed citations
7.
Ayesa‐Arriola, Rosa, José Manuel Rodríguez-Sánchez, Rocío Pérez‐Iglesias, et al.. (2013). Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology. 227(4). 615–625. 26 indexed citations
8.
Crespo‐Facorro, Benedicto, Rocío Pérez‐Iglesias, Ignácio F. Mata, et al.. (2013). Aripiprazole, Ziprasidone, and Quetiapine in the Treatment of First-Episode Nonaffective Psychosis. Journal of Clinical Psychopharmacology. 33(2). 215–220. 17 indexed citations
9.
Ayesa‐Arriola, Rosa, Rocío Pérez‐Iglesias, José Manuel Rodríguez-Sánchez, et al.. (2012). Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 43. 23–28. 18 indexed citations
10.
Crespo‐Facorro, Benedicto, Roberto Roiz‐Santiáñez, Rocío Pérez‐Iglesias, et al.. (2011). Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: The effect on cognitive functioning. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(2). 616–623. 19 indexed citations
11.
Crespo‐Facorro, Benedicto, Rocío Pérez‐Iglesias, Ignácio F. Mata, et al.. (2010). Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. Journal of Psychiatric Research. 45(6). 763–769. 21 indexed citations
12.
Roiz‐Santiáñez, Roberto, Rocío Pérez‐Iglesias, Carlos Quintero, et al.. (2010). Insular cortex thinning in first episode schizophrenia patients. Psychiatry Research Neuroimaging. 182(3). 216–222. 22 indexed citations
13.
Kyriakopoulos, Marinos, Rocío Pérez‐Iglesias, James B. Woolley, et al.. (2009). Effect of age at onset of schizophrenia on white matter abnormalities. The British Journal of Psychiatry. 195(4). 346–353. 60 indexed citations
14.
Mata, Ignácio F., Rocío Pérez‐Iglesias, Roberto Roiz‐Santiáñez, et al.. (2009). Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage. 53(3). 1016–1022. 37 indexed citations
15.
Pérez‐Iglesias, Rocío, José Luis Vázquez‐Barquero, José Amado, et al.. (2008). Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment. Journal of Clinical Psychopharmacology. 28(3). 289–295. 72 indexed citations
16.
Mata, Ignácio F., Rocío Pérez‐Iglesias, Roberto Roiz‐Santiáñez, et al.. (2008). A Neuregulin 1 Variant Is Associated with Increased Lateral Ventricle Volume in Patients with First-Episode Schizophrenia. Biological Psychiatry. 65(6). 535–540. 41 indexed citations
17.
Crespo‐Facorro, Benedicto, Roberto Roiz‐Santiáñez, Rocío Pérez‐Iglesias, et al.. (2008). Effect of antipsychotic drugs on brain morphometry.. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(8). 1936–1943. 43 indexed citations
18.
Palma, Silvia, et al.. (2007). Smoking among pregnant women in Cantabria (Spain): trend and determinants of smoking cessation. BMC Public Health. 7(1). 65–65. 27 indexed citations
19.
Pelayo‐Terán, José María, Benedicto Crespo‐Facorro, Eugenio Carrasco‐Marín, et al.. (2007). Catechol‐O‐methyltransferaseVal158Metpolymorphism and clinical characteristics in first episode non‐affective psychosis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(5). 550–556. 18 indexed citations
20.
González‐Blanch, César, Benedicto Crespo‐Facorro, Mario Álvarez‐Jiménez, et al.. (2006). Cognitive dimensions in first-episode schizophrenia spectrum disorders. Journal of Psychiatric Research. 41(11). 968–977. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026